Highlights Bio-Thera Solutions, Ltd.

Equities

688177

CNE100003R98

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
33.12 ^CNY	-0.51%		+14.21%	-19.69%

Apr. 29	Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 25	Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	Mar. 25	CI
Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company	Mar. 20	MT
Bio-Thera Solutions, Ltd. Partners with SteinCares to Market Two Biosimilars in LATAM	Mar. 18	CI
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Bio-Thera Solutions Announces Initiation of Phase IB / IIA Clinical Trial for BAT6026	Feb. 01	CI
Bio-Thera Solutions Gets Regulatory Nod for Trial of Tumor Drug Combination Treatment	Jan. 12	MT
Bio-Thera Solutions Wins US FDA Nod to Market Cancer Drug	Dec. 08	MT
FDA Approves Bio-Thera Solutions' Avzivi (Bevacizumab-Tnjn), A Biosimilar Referencing Avastin	Dec. 07	CI
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara	Nov. 29	CI
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement	23-10-24	MT
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar	23-10-23	MT
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug	23-10-23	RE
FDA Approves Bio-Thera Solutions, Ltd.'s Partner Biogen Receives Notification from the United States Food and Drug Administration	23-10-08	CI
Biogen Says US FDA Approves Tocilizumab Biosimilar Tofidence	23-09-29	MT
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Bio-Thera Solutions, Ltd. Announces Positive Phase 1 Clinical Data for Bat8006 (Folate-Receptor-A-Adc) and Presents Phase 1 Dose Escalation Study At the Bethune Obstetrics and Gynecology Forum	23-08-12	CI
Chugai Pharmaceutical Files Patent Infringement Lawsuit Against Biogen, Bio-Thera	23-07-18	MT
Bio-Thera Solutions Expands Partnership with Biomm in Brazil with Addition of BAT2206, A Stelara Biosimilar	23-06-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio-Thera Solutions, Ltd.

Equities

688177

CNE100003R98

Highlights

Filters